Net Asset Value(s)

A Tabula ICAV table lists Janus Henderson AAA CLO Active Core UCITS ETF with a valuation date of 27 October 2026. It reports 40,223,654 shares in issue and zero shares redeemed since the previous valuation; the displayed net asset value begins at EUR 424,103,614, but the figure is cut off and no NAV per share is shown.

Analysis

This is a fund-level accounting disclosure, not evidence of a change in credit fundamentals or investor demand. Zero reported redemptions for the stated interval is too narrow to establish durable flows or secondary-market liquidity. The key market mechanism to monitor is whether the ETF’s traded price tracks its reported NAV: if underlying CLO marks are stale or less liquid than the ETF shares, stress could appear first as a widening discount and only later in reported NAV. The extract does not provide a usable NAV-per-share figure or market price, so neither premium/discount nor valuation quality can be assessed. Near term, the notice alone is unlikely to be a catalyst. Over the next 1–3 months, spreads, defaults and recovery assumptions in the fund’s actual holdings matter more; over 6–18 months, sustained deterioration in CLO collateral could pressure marks and liquidity. No directional position is supported by this filing. Verify the full holdings, NAV-per-share field, traded price and flow history before drawing conclusions.

Key Decisions for Investors

• No trade on this disclosure alone; do not interpret one interval of zero redemptions as proof of stable demand or liquidity.
• Watch the ETF’s premium/discount to NAV and bid-ask spread; a persistent discount or abrupt spread widening would be a more actionable stress signal than this filing.
• Before taking exposure, verify the complete NAV-per-share disclosure, portfolio composition, rating and tranche mix, and multi-period creations/redemptions.
• Reassess if CLO credit spreads widen materially, collateral defaults/recoveries deteriorate, or the fund reports sustained outflows; those developments would challenge the benign interpretation.